31 results about "Stem cell product" patented technology

Stem cells products having the potential to support cells of a soft tissue lineage, and methods of preparation and use of those stem cell products are disclosed. The invention also relates to methods for the use of such stem cells products in the regeneration and repair of soft tissue, and in cell-based therapies for of soft tissue conditions.

The described invention provides pharmaceutical compositions for treating an infarct area injury and methods of treating or repairing the infarct area injury in a revascularized subject in the aftermath of an acute myocardial infarction resulting from a natural disease process by administering to the subject parenterally through a catheter a sterile pharmaceutical composition containing a therapeutically effective amount of a nonexpanded sterile isolated chemotactic hematopoietic stem cell product as a first therapeutic agent and optionally a therapeutically effective amount of at least one compatible second therapeutic agent. The infarct area-improving amount of the sterile isolated chemotactic hematopoietic stem cell product comprises an enriched population of isolated autologous CD34+ cells containing a subpopulation of potent cells expressing CXCR-4 and having CXCR-4-mediated chemotactic activity such that the enriched population of isolated autologous CD34+ hematopoietic stem cells provides at least 0.5×106 potent CD34+ cells expressing CXCR-4 and having CXCR-4 mediated chemotactic activity.

The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of cells having chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.

The invention discloses a preparation method of a bovine umbilical cord active ingredient extracting solution and an application of the extracting solution in human skin repair. According to the method, a supernatant containing bovine umbilical cord active ingredients is prepared with a method including cleaning, crushing, homogenizing and crushing and taking and filtering of the supernatant, andthe supernatant is adjusted to a stock solution with proper concentration. Glutathione is added to the stock solution in a certain proportion to increase the antioxidant function of skin, dipotassiumglycyrrhizinate is added to reduce the allergic reaction of skin, so that a human skin repair product is prepared and applied to repair of human skin. Compared with other cosmetic products, the extracting solution has the advantages that the problem of stem cell stemness loss generally exists in ordinary stem cell products is solved, all components of wharton's jelly in bovine umbilical cord are reserved, meanwhile, antioxidant and antiallergic components are added and have the synergistic effect with the bovine umbilical cord active ingredients, nutrition and repair of skin are better facilitated, and the extracting solution is low in cost and simple to prepare and has remarkable industrial application prospects.